Editorial overview: Paths of least resistance: surveillance, discovery, and innovation to address the other (antimicrobial resistance) pandemic

Curr Opin Microbiol. 2020 Oct:57:iii-v. doi: 10.1016/j.mib.2020.11.003.

Authors

Iruka N Okeke¹, Audrey R Odom John²

Affiliations

¹ Department of Pharmaceutical Microbiology, Faculty of Pharmacy, University of Ibadan, Ibadan, Oyo State, Nigeria. Electronic address: iruka.n.okeke@gmail.com.
² Division of Infectious Diseases, Department of Pediatrics, Children's Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. Electronic address: johna3@email.chop.edu.

PMID: 33279100
DOI: 10.1016/j.mib.2020.11.003

No abstract available

Publication types

Editorial

MeSH terms

Anti-Bacterial Agents / pharmacology*
Bacteria / drug effects
Bacteria / genetics
Bacteria / metabolism
Bacterial Infections / drug therapy
Bacterial Infections / epidemiology
Bacterial Infections / microbiology
COVID-19 / epidemiology
COVID-19 / therapy
Drug Discovery
Drug Resistance, Bacterial*
Humans
Pandemics

Substances

Anti-Bacterial Agents